Managing expense and expectation in a treatment revolution: Problematizing prioritisation through an exploration of hepatitis C treatment ‘benefit’
Author:
Funder
The National Institute of Health Research
Publisher
Elsevier BV
Subject
Health Policy,Medicine (miscellaneous)
Reference33 articles.
1. Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States;Barua;Annals of Internal Medicine,2015
2. Resolute efforts to cure hepatitis C: Understanding patients’ reasons for completing antiviral treatment;Clark;Health,2015
3. Notions of injecting drug users’ candidacy for hepatitis C treatment: Conflicting provider, patient and public health perspectives;Coupland;Contemporary Drug Problems,2010
4. Global policy and access to new hepatitis C therapies for people who inject drugs;Doyle;International Journal of Drug Policy,2015
5. Making disease, making citizens: The politics of hepatitis C;Fraser,2011
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. What is a cure through gene therapy? An analysis and evaluation of the use of “cure”;Medicine, Health Care and Philosophy;2024-08-22
2. The time of cure: hepatitis C treatment and the matter of reinfection among people who inject drugs;Health Sociology Review;2024-01-02
3. Countering ‘the moral science of biopolitics’: Understanding hepatitis C treatment ‘non‐compliance’ in the antiviral era;Sociology of Health & Illness;2023-09-23
4. Optimism and eternal vigilance: Gathering disease, responsible subjects and the hope of elimination in the new hepatitis C treatment era;International Journal of Drug Policy;2023-09
5. ‘I’m not hep C free’: afterlives of hepatitis C in the era of cure;Medical Humanities;2023-07-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3